Risk-Tolerant Investors Should Take A Chance On Solid Biosciences Inc (NASDAQ: SLDB)
During the last session, Solid Biosciences Inc (NASDAQ:SLDB)’s traded shares were 0.87 million, with the beta value of the company hitting 2.23. At the end
During the last session, Solid Biosciences Inc (NASDAQ:SLDB)’s traded shares were 0.87 million, with the beta value of the company hitting 2.23. At the end
In the last trading session, 1.25 million shares of the Solid Biosciences Inc (NASDAQ:SLDB) were traded, and its beta was 2.22. Most recently the company’s
Solid Biosciences Inc (NASDAQ:SLDB)’s traded shares stood at 1.78 million during the last session, with the company’s beta value hitting 2.20. At the close of
In the last trading session, 4.05 million Solid Biosciences Inc (NASDAQ:SLDB) shares changed hands as the company’s beta touched 2.14. With the company’s per share
In last trading session, Solid Biosciences Inc (NASDAQ:SLDB) saw 2.41 million shares changing hands with its beta currently measuring 2.18. Company’s recent per share price
Solid Biosciences Inc (NASDAQ:SLDB) has a beta value of 2.27 and has seen 2.16 million shares traded in the last trading session. The company, currently
Solid Biosciences Inc (NASDAQ:SLDB)’s traded shares stood at 1.46 million during the last session, with the company’s beta value hitting 2.33. At the close of
In the last trading session, 1.02 million Solid Biosciences Inc (NASDAQ:SLDB) shares changed hands as the company’s beta touched 2.30. With the company’s per share
In last trading session, Solid Biosciences Inc (NASDAQ:SLDB) saw 1.54 million shares changing hands with its beta currently measuring 2.27. Company’s recent per share price
© 2024, Powered by Smart TechOne